Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
Plos One
|
June 10, 2025
Self-care in haemodialysis treatment tasks in community and hospital-based units: A cross-sectional study
Chava Kurtz, Efrat Shadmi, Karl Skorecki, et al.
Frontiers in Physiology
|
October 30, 2020
ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle
Zaid Abassi, Abd Al Roof Higazi, Safa Kinaneh, et al.
Archives of Internal Medicine
|
October 31, 2012
Body mass index in 1.2 million adolescents and risk for end-stage renal disease
Asaf Vivante, Eliezer Golan, Dorit Tzur, et al.
Lancet (London, England)
|
August 21, 2022
WHO's Palestinian statistics: what's Israel got to do with it?
Karl Skorecki, Rafi Beyar, Rivka Carmi, et al.
Cells
|
April 23, 2020
MiR193a Modulation and Podocyte Phenotype
Alok Jha, Shourav Saha, Kamesh Ayasolla, et al.
Experimental and Molecular Pathology
|
March 23, 2015
Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu
Xiqian Lan, Hongxiu Wen, Moin A Saleem, et al.
BMC Medical Genomics
|
October 20, 2010
Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
Liran I Shlush, Sivan Bercovici, Walter G Wasser, et al.
American Journal of Physiology. Cell Physiology
|
May 1, 2015
Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1
Atanu K Khatua, Amber M Cheatham, Etty D Kruzel, et al.
Experimental and Molecular Pathology
|
June 21, 2015
Protein domains of APOL1 and its risk variants
Xiqian Lan, Hongxiu Wen, Rivka Lederman, et al.
Bioscience Reports
|
April 8, 2017
Effect of <i>APOL1</i> disease risk variants on <i>APOL1</i> gene product
Shabirul Haque, Gauri Patil, Abheepsa Mishra, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
Plos One
|
June 10, 2025
Self-care in haemodialysis treatment tasks in community and hospital-based units: A cross-sectional study
Chava Kurtz, Efrat Shadmi, Karl Skorecki, et al.
Frontiers in Physiology
|
October 30, 2020
ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle
Zaid Abassi, Abd Al Roof Higazi, Safa Kinaneh, et al.
Archives of Internal Medicine
|
October 31, 2012
Body mass index in 1.2 million adolescents and risk for end-stage renal disease
Asaf Vivante, Eliezer Golan, Dorit Tzur, et al.
Lancet (London, England)
|
August 21, 2022
WHO's Palestinian statistics: what's Israel got to do with it?
Karl Skorecki, Rafi Beyar, Rivka Carmi, et al.
Cells
|
April 23, 2020
MiR193a Modulation and Podocyte Phenotype
Alok Jha, Shourav Saha, Kamesh Ayasolla, et al.
Experimental and Molecular Pathology
|
March 23, 2015
Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu
Xiqian Lan, Hongxiu Wen, Moin A Saleem, et al.
BMC Medical Genomics
|
October 20, 2010
Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
Liran I Shlush, Sivan Bercovici, Walter G Wasser, et al.
American Journal of Physiology. Cell Physiology
|
May 1, 2015
Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1
Atanu K Khatua, Amber M Cheatham, Etty D Kruzel, et al.
Experimental and Molecular Pathology
|
June 21, 2015
Protein domains of APOL1 and its risk variants
Xiqian Lan, Hongxiu Wen, Rivka Lederman, et al.
Bioscience Reports
|
April 8, 2017
Effect of <i>APOL1</i> disease risk variants on <i>APOL1</i> gene product
Shabirul Haque, Gauri Patil, Abheepsa Mishra, et al.
Page
of 14